eHealth Summit: "Case Study: How Finland became a leader in eHealth adoption"...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Maritta Korhonen, head of development, Ministry of Social Affairs and Health, Finland.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
eHealth Summit: "EU Address: The EU eHealth Strategy: Connecting Member State...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Dr Tapani Phia, Head of Unit, eHealth & Health Technology Assessment, European Commission.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
The Government proposes a new act on the secondary use of health and social data. The aim is to ensure flexible and secure use of data by establishing a centralised electronic licence service and a licensing authority for the secondary use of health and social data.
eHealth Summit: "ICT Use in Irish General Practices: An Intra-Practice Adopti...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Jane Bourke, Lecturer in Economics, University College Cork.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
eHealth Summit: "Case Study: How Finland became a leader in eHealth adoption"...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Maritta Korhonen, head of development, Ministry of Social Affairs and Health, Finland.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
eHealth Summit: "EU Address: The EU eHealth Strategy: Connecting Member State...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Dr Tapani Phia, Head of Unit, eHealth & Health Technology Assessment, European Commission.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
The Government proposes a new act on the secondary use of health and social data. The aim is to ensure flexible and secure use of data by establishing a centralised electronic licence service and a licensing authority for the secondary use of health and social data.
eHealth Summit: "ICT Use in Irish General Practices: An Intra-Practice Adopti...3GDR
Slides from National eHealth Summit, 30 Sept 2015 at Carton House, Kildare: Jane Bourke, Lecturer in Economics, University College Cork.
#eHealthSummit15
http://www.ehealthsummit.ie
http://mhealthinsight.com/2015/09/25/mhealth-insights-from-the-ehealth-summit/
Legal and regulatory challenges to data sharing for clinical genetics and ge...Human Variome Project
There are many factors that impede genomic variant sharing in the UK, despite it becoming a necessary part of clinical care. These include the lack of a designated infrastructure or mechanism aggravated by the complexity of laws that apply, and fragmented and variable advice from local ‘Caldicott guardians’ who guide NHS trusts on their responsibilities concerning data protection and confidentiality. Since the legitimacy of data sharing in the UK is framed in terms of ‘personal data’ being shared for ‘direct care’ (subject to legal exceptions), the blurred boundaries between clinical care and research, and the spectrum of identifiability of data also lead to differing interpretations resulting in inconsistent practices.
In a multidisciplinary collaboration, the PHG Foundation and the UK’s Association for Clinical Genetic Science co-hosted a workshop to examine the clinical necessity for sharing variant data and associated phenotypic information, the technical feasibility and the legal and regulatory impediments to such sharing. Delegates included clinicians, laboratory scientists, and key policy makers, including the National Data Guardian for Health and Care and representatives from the 100,000 Genomes Project, a pioneering research project which promises to build a legacy for future genomics services in the UK. The key finding from our work was that current arrangements for sharing genomic variants within the NHS are unsatisfactory and inconsistent practices are compromising safety and quality. Our workshop report [1] highlights the urgent need for (i) national agreement to optimise sharing within the NHS and develop consensus on the legitimacy of data sharing, (ii) standardised operational processes, including a designated sustainable database or mechanism for sharing, and (iii) strong leadership by the multiple relevant health organisations to demonstrate the benefits and risks associated with sharing and not sharing data.
Since publication of the workshop report, the NHS Consortium (operating within the DECIPHER database) has reported a 120% increase in the number of cases shared, the 100,000 Genomes Project and associated data embassy have got underway and the EU Data Protection Regulation has been finalised. However research highlights continuing public reservations about some aspects of data sharing including commercial access and misgivings around secondary uses of data. Publication of the National Data Guardian’s long-awaited review of consent and security provisions to provide guidance on a new consent and opt-out model for sharing patient information in the NHS, has been delayed pending the results of the EU referendum being known. Against this backdrop, the imperative to develop robust, proportionate policies for genomic data sharing becomes increasingly acute.
Funding from the PHG Foundation and the Association for Clinical Genetic Science.
This review by the National Data Guardian for Health and Care (NDG), Dame Fiona Caldicott, makes recommendations to the Secretary of State for Health. These are aimed at strengthening the safeguards for keeping health and care information secure and ensuring the public can make informed choices about how their data is used.
The NDG proposes new data security standards for the NHS and social care, a method for testing compliance against the standards, and a new opt-out to make clear how people’s health and care information will be used and in what circumstances they can opt out.
Dame Fiona’s report argues that the public should be engaged about how their information is used and safeguarded, and the benefits of data sharing, with a wide-ranging consultation on her proposals as a first step.
A letter from Dame Fiona Caldicott and David Behan, Care Quality Commission Chief Executive, to the Health Secretary outlines the common themes between the NDG review and a review of data security in the NHS carried out by the CQC.
Presentation made by Professor Martin Severs, HSCIC Caldicott Guardian and Lead Clinician, at the Healthcare Conferences UK event 'Information Governance Implementing the Government Response to Caldicott2', to preview the new HSCIC Code of Practice on Confidential Information. This event was held at London's Hallam Conference Centre, on Wednesday 12 November 2014.
Greater Manchester's visionary approach to integrated care
Delivered by the Greater Manchester Health and Social Care Partnership
Day Two, Pop-up University 8, 16.00
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Building public trust in the use of health and care data
1. Building public trust in the use of health and care data
NHS Expo
Thursday 8 September 2016
Dame Fiona Caldicott
National Data Guardian for Health and Care
2. National
Data
Guardian
The National Data Guardian for Health and Care (NDG)
Government has committed to putting into law a role that:
o is an independent and authoritative champion for the public
o considers the uses made of data health and care data
o has formal advice giving powers
o does not issue or enforce sanctions but works with existing
regulators
3. National
Data
Guardian
The NDG review of Data Security, Consent and Opt-outs
o Secretary of State commissioned in September 2015
o Care Quality Commission (CQC) reviewed current approaches to
data security across the NHS
o The National Data Guardian asked to propose
a set of data security standards applicable across the NHS and
social care system
a method to assess compliance with CQC
new model of consent /opt outs
o Strong common themes across NDG and CQC findings
4. National
Data
Guardian
A strong evidence base
Proposals developed iteratively with input from wide range of
stakeholders, including:
o Patients and service user groups
o Clinicians, Royal Colleges, British Medical Association
o Information Commissioner's Office
o Service providers
o Commissioners
o NHS Digital
o Research community
o Civil society
o Providers of IT systems
o Data security experts
o UK Caldicott Guardian Council
5. National
Data
Guardian
Altruism and scepticism
o Little knowledge among general public about how data is used
o Benefits may be clear to experts – but not yet to public
o Our evidence shows that most people want to support their
data being used to improve care…
o …but transparency, security, and red lines matter
o …and people expect a choice
o Spectrum of opinion
6. National
Data
Guardian
Recommendations: NDG Data Security Standards
Ten new standards, grouped under three themes – people,
processes, technology
Key data security recommendation:
The leadership of every organisation should
demonstrate clear ownership and responsibility
for data security, just as it does for clinical and
financial management and accountability.
7. National
Data
Guardian
Recommendations: opt-out
1. You are protected by the law.
2. Information is essential for high quality care.
3. Information is essential for other beneficial purposes.
4. You have the right to opt out of your personal confidential information being used
for these other purposes beyond your direct care:
A. Personal confidential information being used to provide local services and in running
the NHS and social care system.
B. Personal confidential information being used to support research and improve
treatment and care.
5. This opt-out will be respected by all organisations that use health and social care
information.
6. Explicit consent will continue to be possible.
7. The opt-out will not apply to anonymised information.
8. Arrangements will continue to cover exceptional circumstances.
9. National
Data
Guardian
What next?
o Recommendations accepted in principle by Government
o Department of Health written consultation ended yesterday.
Some additional testing and engagement continues.
o Nothing changes yet
o Ongoing conversation with the public needed
o Implementation will not be overnight
o NDG also looking at other topics, for example sharing
of genetic data to support patient care
10. National
Data
Guardian
Thanks
Katie Farrington and her independent review team
The National Data Guardian Panel
The National Data Guardian Office team
And many more including…
38 degrees
Alzheimer’s Research
Academy of Medical Royal Colleges
Association of Directors of Adult Social Services
Association of Medical Research Charities
Asthma UK
British Heart Foundation
British Medical Association
Cabinet Office
Cancer Research UK
Care Quality Commission
Centre of Excellence in Information Sharing
Chief Medical Officer
Department of Health
Equality and Human Rights Commission
Health Research Authority
Healthwatch
Information Commissioner’s Office
Information Governance Alliance
Liberty
Local Government Association
Local Government UK
Macmillan Cancer Support
MedConfidential
Medical Research Council
Medicines and Healthcare Products Regulatory Agency
Mind
MQ: Transforming Mental Health
National Voices
NHS Digital
NHS England
NHS Improvement
Nuffield Council on Bioethics
Public Health England
Richmond Group
Royal College of General Practitioners
Royal College of Nursing
Royal College of Physicians of London
Royal College of Psychiatrists
Royal Statistical Society
Skills For Care
Society of Local Authority Chief Executives and Senior
Managers
The Patients Association
Tech UK
UK Council of Caldicott Guardians
Wellcome Trust
Additional points that could be made
looks at data collected within the health and care system ---- but is able to challenge and scrutinise where it is shared more widely
Organisations must show how they have responded to NDG advice
Spectrum of opinion - in the King’s Fund speech, we had the following wording:
We must be realistic that there is a wide spectrum of opinion about these matters and that wherever we draw the line to balance the interests of confidentiality and the benefits that can be gained by using data, some people will be unhappy.
I thought this might be a way of summarising the very top messages and leading into the call for a much better public conversation about data sharing.
Could mention the Wellcome taskforde here, especially as Aisling is involved in it and should be on the panel (tbc)